These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 33867900)
21. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern. Akkız H Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924 [TBL] [Abstract][Full Text] [Related]
22. A Beta Strain-Based Spike Glycoprotein Vaccine Candidate Induces Broad Neutralization and Protection against SARS-CoV-2 Variants of Concern. Cao L; Guo J; Li H; Ren H; Xiao K; Zhang Y; Zhu S; Song Y; Zhao W; Wu D; Chen Z; Zhang Y; Xia B; Ji T; Yan D; Wang D; Yang Q; Zhou Y; Li X; Hou Z; Xu W Microbiol Spectr; 2023 Feb; 11(2):e0268722. PubMed ID: 36847495 [TBL] [Abstract][Full Text] [Related]
23. Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity. Mengist HM; Kombe Kombe AJ; Mekonnen D; Abebaw A; Getachew M; Jin T Semin Immunol; 2021 Jun; 55():101533. PubMed ID: 34836774 [TBL] [Abstract][Full Text] [Related]
24. Scope of SARS-CoV-2 variants, mutations, and vaccine technologies. Wambani J; Okoth P Egypt J Intern Med; 2022; 34(1):34. PubMed ID: 35368846 [TBL] [Abstract][Full Text] [Related]
25. COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants. Noor R; Shareen S; Billah M Bull Natl Res Cent; 2022; 46(1):96. PubMed ID: 35431535 [TBL] [Abstract][Full Text] [Related]
26. Comparison of BNT162b2-, mRNA-1273- and Ad26.COV2.S-Elicited IgG and Neutralizing Titers against SARS-CoV-2 and Its Variants. Padhiar NH; Liu JB; Wang X; Wang XL; Bodnar BH; Khan S; Wang P; Khan AI; Luo JJ; Hu WH; Ho WZ Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746466 [TBL] [Abstract][Full Text] [Related]
28. Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern. Rudi E; Martin Aispuro P; Zurita E; Gonzalez Lopez Ledesma MM; Bottero D; Malito J; Gabrielli M; Gaillard E; Stuible M; Durocher Y; Gamarnik AV; Wigdorovitz A; Hozbor D Front Immunol; 2022; 13():1020159. PubMed ID: 36248791 [TBL] [Abstract][Full Text] [Related]
29. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines. Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287 [TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants. Martínez-Flores D; Zepeda-Cervantes J; Cruz-Reséndiz A; Aguirre-Sampieri S; Sampieri A; Vaca L Front Immunol; 2021; 12():701501. PubMed ID: 34322129 [TBL] [Abstract][Full Text] [Related]
32. Dynamical changes of SARS-CoV-2 spike variants in the highly immunogenic regions impact the viral antibodies escaping. Di Rienzo L; Miotto M; Desantis F; Grassmann G; Ruocco G; Milanetti E Proteins; 2023 Aug; 91(8):1116-1129. PubMed ID: 37078559 [TBL] [Abstract][Full Text] [Related]
33. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
34. Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study. Tut G; Lancaster T; Krutikov M; Sylla P; Bone D; Kaur N; Spalkova E; Bentley C; Amin U; Jadir AT; Hulme S; Butler MS; Ayodele M; Bruton R; Shrotri M; Azmi B; Fuller C; Irwin-Singer A; Hayward A; Copas A; Shallcross L; Moss P Lancet Healthy Longev; 2021 Sep; 2(9):e544-e553. PubMed ID: 34430954 [TBL] [Abstract][Full Text] [Related]